Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SUPRIYA.NSthis companySupriya Lifescience Limited	₹631.25	21.63×	3.78×	5.46×	14.72×	-83.4%	54.2%	32.1%	25.3%	17.5%	16.4%	1.0%	0×	-0.11×	140.62×	4.4×	0.2%	5	—	1	C-
AARTIPHARM.NSAarti Pharmalabs Limited	₹921.40	32.96×	2.71×	3.16×	16.93×	-152.7%	54.1%	16.4%	9.6%	8.2%	7.3%	-3.2%	0.36×	1.94×	6.36×	1.49×	0.6%	6	4.24	3	B-
ALIVUS.NSAlivus Life Sciences Limited	₹1,474.40	21.18×	3.59×	4.69×	14.44×	-46.0%	44.6%	28.3%	22.1%	16.9%	15.6%	2.2%	0.02×	0.07×	134.39×	5.21×	0.5%	—	—	4	A-
BAJAJHCARE.NSBajaj Healthcare Ltd	₹315.25	58.25×	1.72×	1.5×	14.35×	-51.1%	33.4%	12.6%	2.6%	3.0%	7.2%	-0.7%	0.47×	2.68×	3.48×	1.71×	0.3%	2	2.61	2	C+
GRANULES.NSGranules India Limited	₹799.20	25.35×	2.97×	2.81×	13.13×	-42.2%	43.0%	16.6%	11.1%	11.7%	10.1%	0.8%	0.3×	0.52×	7.77×	1.8×	0.2%	5	—	2	C+
HIKAL.NSHikal Limited	₹225.40	-37.14×	1.51×	1.06×	16.85×	-107.8%	30.2%	3.3%	-2.8%	-4.1%	1.8%	4.9%	0.57×	4.57×	0.91×	1.3×	0.7%	3	—	1	C-
Peer median	—	25.35×	2.71×	2.81×	14.44×	-51.1%	43.0%	16.4%	9.6%	8.2%	7.3%	0.8%	0.36×	1.94×	6.36×	1.71×	0.5%	4	3.42	2	—